Shanghai Shyndec Pharmaceutical Co., Ltd. (SHA:600420)
China · Delayed Price · Currency is CNY 8.70
-0.20 (-2.25%)
Jun 9, 2026, 3:00 PM CST
SHA:600420 Revenue
Shanghai Shyndec Pharmaceutical had revenue of 2.06B CNY in the quarter ending March 31, 2026, a decrease of -20.81%. This brings the company's revenue in the last twelve months to 8.82B, down -15.36% year-over-year. In the year 2025, Shanghai Shyndec Pharmaceutical had annual revenue of 9.36B, down -14.39%.
Revenue (ttm)
8.82B
Revenue Growth
-15.36%
P/S Ratio
1.32
Revenue / Employee
909.62K
Employees
9,697
Market Cap
11.67B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.36B | -1.57B | -14.39% |
| Dec 31, 2024 | 10.94B | -1.13B | -9.38% |
| Dec 31, 2023 | 12.07B | -889.39M | -6.86% |
| Dec 31, 2022 | 12.96B | -985.63M | -7.07% |
| Dec 31, 2021 | 13.94B | 1.39B | 11.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition